U.S. Agency to Review Wisconsin Stem Cell Patents
<p class="source">Bloomberg News</p>
<p>The patents will be reassessed because there's "a substantial likelihood" that previous research by other scientists could supersede the Wisconsin claims, the U.S. Patent and Trademark Office said in a statement on its website.</p>
